{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:32:28Z","timestamp":1779399148605,"version":"3.53.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mucositis is an inflammatory condition of the gut, caused by an adverse effect of chemotherapy drugs, such as 5-fluorouracil (5-FU). In an attempt to develop alternative treatments for the disease, several research groups have proposed the use of probiotics, in particular, Lactic Acid Bacteria (LAB). In this context, the use of recombinant LAB, for delivering anti-inflammatory compounds has also been explored. In previous work, we demonstrated that either<jats:italic>Lactococcus lactis<\/jats:italic>NZ9000 or a recombinant strain expressing an antimicrobial peptide involved in human gut homeostasis, the Pancreatitis-associated Protein (PAP), could ameliorate 5-FU-induced mucositis in mice. However, the impact of these strains on the gut microbiota still needs to be elucidated. Therefore, in the present study, we aimed to characterize the effects of both<jats:italic>Lactococci<\/jats:italic>strains in the gut microbiome of mice through a 16\u2009S rRNA gene sequencing metagenomic approach. Our data show 5-FU caused a significant decrease in protective bacteria and increase of several bacteria associated with pro-inflammatory traits. The<jats:italic>Lactococci<\/jats:italic>strains were shown to reduce several potential opportunistic microbes, while PAP delivery was able to suppress the growth of<jats:italic>Enterobacteriaceae<\/jats:italic>during inflammation. We conclude the strain secreting antimicrobial PAP was more effective in the control of 5-FU-dysbiosis.<\/jats:p>","DOI":"10.1038\/s41598-018-33469-w","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:59:22Z","timestamp":1538650762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Gut microbiome modulation during treatment of mucositis with the dairy bacterium Lactococcus lactis and recombinant strain secreting human antimicrobial PAP"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0216-7173","authenticated-orcid":false,"given":"Rodrigo","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Luiz","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Dorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8143-5756","authenticated-orcid":false,"given":"Eric","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Chatel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Langella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4897-8521","authenticated-orcid":false,"given":"Gabriel","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1022-6842","authenticated-orcid":false,"given":"Henrique","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arist\u00f3teles","family":"Goes-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"33469_CR1","first-page":"2075","volume":"21","author":"N Al-Dasooqi","year":"2013","unstructured":"Al-Dasooqi, N. et al. Emerging evidence on the pathobiology of mucositis. Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer 21, 2075\u20132083 (2013).","journal-title":"Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer"},{"key":"33469_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00280-008-0732-8","volume":"63","author":"RM Logan","year":"2009","unstructured":"Logan, R. M. et al. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother. Pharmacol. 63, 239\u2013251 (2009).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"33469_CR3","doi-asserted-by":"publisher","unstructured":"Ryck, T. D. et al. Effects of Irradiation on Epithelial Wound Healing and Microbial Diversity in an in-vitro Oral Mucosa Model. J. Nucl. Med. Radiat. Ther. https:\/\/doi.org\/10.4172\/2155-9619.1000218 (2015).","DOI":"10.4172\/2155-9619.1000218"},{"key":"33469_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1365-2036.2003.01784.x","volume":"18","author":"M Duncan","year":"2003","unstructured":"Duncan, M. & Grant, G. Oral and intestinal mucositis - causes and possible treatments. Aliment. Pharmacol. Ther. 18, 853\u2013874 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"33469_CR5","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1099\/mic.0.000149","volume":"161","author":"SHSP Pedroso","year":"2015","unstructured":"Pedroso, S. H. S. P. et al. Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice. Microbiol. Read. Engl. 161, 1950\u20131960 (2015).","journal-title":"Microbiol. Read. Engl."},{"key":"33469_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander, J. L. et al. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat. Rev. Gastroenterol. Hepatol. 14, 356\u2013365 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"33469_CR7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nrc.2017.13","volume":"17","author":"Soumen Roy","year":"2017","unstructured":"Roy, S. & Trinchieri, G. Microbiota: a key orchestrator of cancer therapy. Nat. Rev. Cancer 17, nrc.2017.13 (2017).","journal-title":"Nature Reviews Cancer"},{"key":"33469_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1158\/1078-0432.CCR-05-0750","volume":"12","author":"G Brandi","year":"2006","unstructured":"Brandi, G. et al. Intestinal microflora and digestive toxicity of irinotecan in mice. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 12, 1299\u20131307 (2006).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"33469_CR9","doi-asserted-by":"publisher","first-page":"e39764","DOI":"10.1371\/journal.pone.0039764","volume":"7","author":"XB Lin","year":"2012","unstructured":"Lin, X. B. et al. Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats. PLOS ONE 7, e39764 (2012).","journal-title":"PLOS ONE"},{"key":"33469_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier, E. et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment. Pharmacol. Ther. 42, 515\u2013528 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"33469_CR11","doi-asserted-by":"publisher","first-page":"e28654","DOI":"10.1371\/journal.pone.0028654","volume":"6","author":"J Zwielehner","year":"2011","unstructured":"Zwielehner, J. et al. Changes in Human Fecal Microbiota Due to Chemotherapy Analyzed by TaqMan-PCR, 454 Sequencing and PCR-DGGE Fingerprinting. PLOS ONE 6, e28654 (2011).","journal-title":"PLOS ONE"},{"key":"33469_CR12","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00280-018-3549-0","volume":"81","author":"C Panebianco","year":"2018","unstructured":"Panebianco, C. et al. Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice. Cancer Chemother. Pharmacol. 81, 773\u2013782 (2018).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"33469_CR13","doi-asserted-by":"crossref","unstructured":"Carvalho, R. D. D. O. et al. Use of Wild Type or Recombinant Lactic Acid Bacteria as an Alternative Treatment for Gastrointestinal Inflammatory Diseases: A Focus on Inflammatory Bowel Diseases and Mucositis. Front. Microbiol. 8, (2017).","DOI":"10.3389\/fmicb.2017.00800"},{"key":"33469_CR14","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.4161\/cbt.6.9.4622","volume":"6","author":"JM Bowen","year":"2007","unstructured":"Bowen, J. M. et al. VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss. Cancer Biol. Ther. 6, 1449\u20131454 (2007).","journal-title":"Cancer Biol. Ther."},{"key":"33469_CR15","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00520-012-1446-3","volume":"20","author":"LD Prisciandaro","year":"2012","unstructured":"Prisciandaro, L. D. et al. Probiotic factors partially prevent changes to caspases 3 and 7 activation and transepithelial electrical resistance in a model of 5-fluorouracil-induced epithelial cell damage. Support. Care Cancer 20, 3205\u20133210 (2012).","journal-title":"Support. Care Cancer"},{"key":"33469_CR16","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s10620-008-0275-1","volume":"53","author":"E Southcott","year":"2008","unstructured":"Southcott, E., Tooley, K. L., Howarth, G. S., Davidson, G. P. & Butler, R. N. Yoghurts containing probiotics reduce disruption of the small intestinal barrier in methotrexate-treated rats. Dig. Dis. Sci. 53, 1837\u20131841 (2008).","journal-title":"Dig. Dis. Sci."},{"key":"33469_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nut.2016.05.003","volume":"33","author":"Y Tang","year":"2017","unstructured":"Tang, Y. et al. Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil\u2013induced intestinal mucositis and dysbiosis in rats. Nutrition 33, 96\u2013104 (2017).","journal-title":"Nutrition"},{"key":"33469_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4161\/cbt.5.6.2659","volume":"5","author":"KL Tooley","year":"2006","unstructured":"Tooley, K. L., Howarth, G. S., Lymn, K. A., Lawrence, A. & Butler, R. N. Oral ingestion of streptococcus thermophilus diminishes severity of small intestinal mucositis in methotrexate treated rats. Cancer Biol. Ther. 5, 593\u2013600 (2006).","journal-title":"Cancer Biol. Ther."},{"key":"33469_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4161\/cbt.12.2.15720","volume":"12","author":"KL Tooley","year":"2011","unstructured":"Tooley, K. L., Howarth, G. S., Lymn, K. A., Lawrence, A. & Butler, R. N. Oral ingestion of Streptococcus thermophilus does not affect mucositis severity or tumor progression in the tumor-bearing rat. Cancer Biol. Ther. 12, 131\u2013138 (2011).","journal-title":"Cancer Biol. Ther."},{"key":"33469_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.4161\/cbt.8.6.7594","volume":"8","author":"EJ Whitford","year":"2009","unstructured":"Whitford, E. J. et al. Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU). Cancer Biol. Ther. 8, 505\u2013511 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"33469_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.nut.2018.03.056","volume":"54","author":"R Levit","year":"2018","unstructured":"Levit, R., S de Giori, G., De Moreno De LeBlanc, A. & LeBlanc, J. G. Protective effect of the riboflavin-overproducing strain Lactobacillus plantarum CRL2130 on intestinal mucositis in mice. Nutrition 54, 165\u2013172 (2018).","journal-title":"Nutrition"},{"key":"33469_CR22","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.oraloncology.2010.04.008","volume":"46","author":"S Caluwaerts","year":"2010","unstructured":"Caluwaerts, S. et al. AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol. 46, 564\u2013570 (2010).","journal-title":"Oral Oncol."},{"key":"33469_CR23","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1002\/cncr.28365","volume":"119","author":"SA Limaye","year":"2013","unstructured":"Limaye, S. A. et al. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer 119, 4268\u20134276 (2013).","journal-title":"Cancer"},{"key":"33469_CR24","doi-asserted-by":"crossref","unstructured":"Carvalho, R. D. et al. Secretion of biologically active pancreatitis-associated protein I (PAP) by genetically modified dairy Lactococcus lactis NZ9000 in the prevention of intestinal mucositis. Microb. Cell Factories 16, (2017).","DOI":"10.1186\/s12934-017-0624-x"},{"key":"33469_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.immuni.2014.12.028","volume":"42","author":"S Mukherjee","year":"2015","unstructured":"Mukherjee, S. & Hooper, L. V. Antimicrobial Defense of the Intestine. Immunity 42, 28\u201339 (2015).","journal-title":"Immunity"},{"key":"33469_CR26","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1590\/1807-3107bor-2017.vol31.0071","volume":"31","author":"D Gerhard","year":"2017","unstructured":"Gerhard, D. et al. Probiotic therapy reduces inflammation and improves intestinal morphology in rats with induced oral mucositis. Braz. Oral Res. 31, e71 (2017).","journal-title":"Braz. Oral Res."},{"issue":"10","key":"33469_CR27","doi-asserted-by":"publisher","first-page":"e0141402","DOI":"10.1371\/journal.pone.0141402","volume":"10","author":"Chun-Yan Yeung","year":"2015","unstructured":"Yeung, C.-Y. et al. Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model. PLoS ONE 10, (2015).","journal-title":"PLOS ONE"},{"key":"33469_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.intimp.2016.12.027","volume":"43","author":"A Berlec","year":"2017","unstructured":"Berlec, A. et al. Dextran sulphate sodium colitis in C57BL\/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor \u03b1. Int. Immunopharmacol. 43, 219\u2013226 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"33469_CR29","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.3748\/wjg.v21.i29.8787","volume":"21","author":"SM Jandhyala","year":"2015","unstructured":"Jandhyala, S. M. et al. Role of the normal gut microbiota. World J. Gastroenterol. WJG 21, 8787\u20138803 (2015).","journal-title":"World J. Gastroenterol. WJG"},{"key":"33469_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1034\/j.1399-302X.2003.00075.x","volume":"18","author":"I B\u00fcltzingsl\u00f6wen","year":"2003","unstructured":"B\u00fcltzingsl\u00f6wen, I., Adlerberth, I., Wold, A. E., Dahl\u00e9n, G. & Jontell, M. Oral and intestinal microflora in 5\u2010fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol. Immunol. 18, 278\u2013284 (2003).","journal-title":"Oral Microbiol. Immunol."},{"key":"33469_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/bcpt.12793","volume":"121","author":"N Hamouda","year":"2017","unstructured":"Hamouda, N. et al. Apoptosis, Dysbiosis and Expression of Inflammatory Cytokines are Sequential Events in the Development of 5-Fluorouracil-Induced Intestinal Mucositis in Mice. Basic Clin. Pharmacol. Toxicol. 121, 159\u2013168 (2017).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"33469_CR32","doi-asserted-by":"crossref","unstructured":"Li, H.-L. et al. Alteration of Gut Microbiota and Inflammatory Cytokine\/Chemokine Profiles in 5-Fluorouracil Induced Intestinal Mucositis. Front. Cell. Infect. Microbiol. 7, (2017).","DOI":"10.3389\/fcimb.2017.00455"},{"key":"33469_CR33","doi-asserted-by":"publisher","first-page":"e76520","DOI":"10.1371\/journal.pone.0076520","volume":"8","author":"C Kang","year":"2013","unstructured":"Kang, C. et al. Extracellular Vesicles Derived from Gut Microbiota, Especially Akkermansia muciniphila, Protect the Progression of Dextran Sulfate Sodium-Induced Colitis. PLOS ONE 8, e76520 (2013).","journal-title":"PLOS ONE"},{"key":"33469_CR34","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1126\/science.1127119","volume":"313","author":"HL Cash","year":"2006","unstructured":"Cash, H. L., Whitham, C. V., Behrendt, C. L. & Hooper, L. V. Symbiotic Bacteria Direct Expression of an Intestinal Bactericidal Lectin. Science 313, 1126\u20131130 (2006).","journal-title":"Science"},{"key":"33469_CR35","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/mi.2013.109","volume":"7","author":"LM Loonen","year":"2014","unstructured":"Loonen, L. M. et al. REG3\u03b3-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol. 7, 939\u2013947 (2014).","journal-title":"Mucosal Immunol."},{"key":"33469_CR36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/apt.12878","volume":"40","author":"Y Touchefeu","year":"2014","unstructured":"Touchefeu, Y. et al. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis \u2013 current evidence and potential clinical applications. Aliment. Pharmacol. Ther. 40, 409\u2013421 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"33469_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000443177","volume":"97","author":"S Pa\u017eourekov\u00e1","year":"2016","unstructured":"Pa\u017eourekov\u00e1, S. et al. Equol Effectively Inhibits Toxic Activity of Human Neutrophils without Influencing Their Viability. Pharmacology 97, 138\u2013145 (2016).","journal-title":"Pharmacology"},{"key":"33469_CR38","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1093\/jn\/132.12.3577","volume":"132","author":"KDR Setchell","year":"2002","unstructured":"Setchell, K. D. R., Brown, N. M. & Lydeking-Olsen, E. The Clinical Importance of the Metabolite Equol\u2014A Clue to the Effectiveness of Soy and Its Isoflavones. J. Nutr. 132, 3577\u20133584 (2002).","journal-title":"J. Nutr."},{"key":"33469_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0014-5793(81)80322-5","volume":"123","author":"M Axelson","year":"1981","unstructured":"Axelson, M. & Setchell, K. D. The excretion of lignans in rats\u2013evidence for an intestinal bacterial source for this new group of compounds. FEBS Lett. 123, 337\u2013342 (1981).","journal-title":"FEBS Lett."},{"key":"33469_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/0030-4220(85)90237-3","volume":"60","author":"BG Seto","year":"1985","unstructured":"Seto, B. G., Kim, M., Wolinsky, L., Mito, R. S. & Champlin, R. Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg. Oral Med. Oral Pathol. 60, 493\u2013497 (1985).","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"33469_CR41","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/S0022-3476(88)80397-4","volume":"113","author":"JL Shenep","year":"1988","unstructured":"Shenep, J. L. et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. J. Pediatr. 113, 758\u2013763 (1988).","journal-title":"J. Pediatr."},{"key":"33469_CR42","doi-asserted-by":"publisher","first-page":"11889","DOI":"10.1073\/pnas.0704662104","volume":"104","author":"Y Marcy","year":"2007","unstructured":"Marcy, Y. et al. Dissecting biological \u2018dark matter\u2019 with single-cell genetic analysis of rare and uncultivated TM7 microbes from the human mouth. Proc. Natl. Acad. Sci. USA 104, 11889\u201311894 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"33469_CR43","doi-asserted-by":"publisher","first-page":"3651","DOI":"10.1099\/00221287-148-11-3651","volume":"148","author":"NH Salzman","year":"2002","unstructured":"Salzman, N. H. et al. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteriab. Microbiology 148, 3651\u20133660 (2002).","journal-title":"Microbiology"},{"key":"33469_CR44","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1128\/AEM.69.3.1687-1694.2003","volume":"69","author":"MM Brinig","year":"2003","unstructured":"Brinig, M. M., Lepp, P. W., Ouverney, C. C., Armitage, G. C. & Relman, D. A. Prevalence of Bacteria of Division TM7 in Human Subgingival Plaque and Their Association with Disease. Appl. Environ. Microbiol. 69, 1687\u20131694 (2003).","journal-title":"Appl. Environ. Microbiol."},{"key":"33469_CR45","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1099\/jmm.0.47719-0","volume":"57","author":"T Kuehbacher","year":"2008","unstructured":"Kuehbacher, T. et al. Intestinal TM7 bacterial phylogenies in active inflammatory bowel disease. J. Med. Microbiol. 57, 1569\u20131576 (2008).","journal-title":"J. Med. Microbiol."},{"key":"33469_CR46","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1271\/bbb.110434","volume":"76","author":"EV Kulagina","year":"2012","unstructured":"Kulagina, E. V. et al. Species composition of Bacteroidales order bacteria in the feces of healthy people of various ages. Biosci. Biotechnol. Biochem. 76, 169\u2013171 (2012).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"33469_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-9-r79","volume":"13","author":"XC Morgan","year":"2012","unstructured":"Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).","journal-title":"Genome Biol."},{"key":"33469_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-230X-10-134","volume":"10","author":"SO Noor","year":"2010","unstructured":"Noor, S. O. et al. Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol. 10, 134 (2010).","journal-title":"BMC Gastroenterol."},{"key":"33469_CR49","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/978-3-319-62431-0_27","volume-title":"Oncoimmunology","author":"M\u00e9lodie Bonvalet","year":"2017","unstructured":"Bonvalet, M., Daill\u00e8re, R., Roberti, M. P., Rauber, C. & Zitvogel, L. The Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer. in Oncoimmunology (eds Zitvogel, L. & Kroemer, G.) 447\u2013462, https:\/\/doi.org\/10.1007\/978-3-319-62431-0_27, (Springer International Publishin., 2018)."},{"key":"33469_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","volume":"11","author":"A Nishida","year":"2018","unstructured":"Nishida, A. et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin. J. Gastroenterol. 11, 1\u201310 (2018).","journal-title":"Clin. J. Gastroenterol."},{"key":"33469_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1046\/j.1365-2672.1999.00627.x","volume":"29","author":"H Kimoto","year":"2002","unstructured":"Kimoto, H., Kurisaki, J., Tsuji, N. M., Ohmomo, S. & Okamoto, T. Lactococci as probiotic strains: adhesion to human enterocyte\u2010like Caco\u20102 cells and tolerance to low pH and bile. Lett. Appl. Microbiol. 29, 313\u2013316 (2002).","journal-title":"Lett. Appl. Microbiol."},{"key":"33469_CR52","doi-asserted-by":"crossref","unstructured":"Saraiva, T. D. L. et al. Lactococcus lactis NCDO2118 produces anti-hypertensive GABA and exerts acute hypotensive in spontaneously hypertensive rats. Med. Res. Arch. 4, (2016).","DOI":"10.18103\/mra.v4i7.620"},{"key":"33469_CR53","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ibd.21366","volume":"17","author":"JM Uronis","year":"2011","unstructured":"Uronis, J. M. et al. Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. Inflamm. Bowel Dis. 17, 289\u2013297 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"33469_CR54","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ijantimicag.2016.07.011","volume":"48","author":"AB Fl\u00f3rez","year":"2016","unstructured":"Fl\u00f3rez, A. B., Sierra, M., Ruas-Madiedo, P. & Mayo, B. Susceptibility of lactic acid bacteria, bifidobacteria and other bacteria of intestinal origin to chemotherapeutic agents. Int. J. Antimicrob. Agents 48, 547\u2013550 (2016).","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"33469_CR55","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/cid\/ciy154","volume":"67","author":"Nicolas Argy","year":"2018","unstructured":"Hakim, H. et al. Gut Microbiome Composition Predicts Infection Risk during Chemotherapy in Children with Acute Lymphoblastic Leukemia. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciy154 (2018).","journal-title":"Clinical Infectious Diseases"},{"key":"33469_CR56","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1128\/JCM.42.2.530-534.2004","volume":"42","author":"E Lindberg","year":"2004","unstructured":"Lindberg, E. et al. High Rate of Transfer of Staphylococcus aureus from Parental Skin to Infant Gut Flora. J. Clin. Microbiol. 42, 530\u2013534 (2004).","journal-title":"J. Clin. Microbiol."},{"key":"33469_CR57","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/08910609509141382","volume":"8","author":"J Bagg","year":"1995","unstructured":"Bagg, J., Sweeney, M. P., Wood, K. H. & Wiggins, A. Possible Role of Staphylococcus aureus in Severe Oral Mucositis among Elderly Dehydrated Patients. Microb. Ecol. Health Dis. 8, 51\u201356 (1995).","journal-title":"Microb. Ecol. Health Dis."},{"key":"33469_CR58","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/089106000435617","volume":"12","author":"MS Jackson","year":"2000","unstructured":"Jackson, M. S. Staphylococci in the oral flora of healthy children and those receiving treatment for malignant disease. Microb. Ecol. Health Dis. 12, 60\u201364 (2000).","journal-title":"Microb. Ecol. Health Dis."},{"key":"33469_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/PL00011241","volume":"20","author":"E Gonz\u00e1lez-Barca","year":"2001","unstructured":"Gonz\u00e1lez-Barca, E., Carratal\u00e1, J., Mykietiuk, A., Fern\u00e1ndez-Sevilla, A. & Gudiol, F. Predisposing Factors and Outcome of Staphylococcus aureus Bacteremia in Neutropenic Patients with Cancer. Eur. J. Clin. Microbiol. Infect. Dis. 20, 117\u2013119 (2001).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"33469_CR60","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1002\/ibd.20500","volume":"14","author":"M Issa","year":"2008","unstructured":"Issa, M., Ananthakrishnan, A. N. & Binion, D. G. Clostridium difficile and inflammatory bowel disease. Inflamm. Bowel Dis. 14, 1432\u20131442 (2008).","journal-title":"Inflamm. Bowel Dis."},{"key":"33469_CR61","doi-asserted-by":"publisher","first-page":"e10667","DOI":"10.1371\/journal.pone.0010667","volume":"5","author":"E Biagi","year":"2010","unstructured":"Biagi, E. et al. Through Ageing, and Beyond: Gut Microbiota and Inflammatory Status in Seniors and Centenarians. PLOS ONE 5, e10667 (2010).","journal-title":"PLOS ONE"},{"key":"33469_CR62","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/jcp.2005.031773","volume":"59","author":"SKP Lau","year":"2006","unstructured":"Lau, S. K. P. et al. Bacteraemia caused by Anaerotruncus colihominis and emended description of the species. J. Clin. Pathol. 59, 748\u2013752 (2006).","journal-title":"J. Clin. Pathol."},{"key":"33469_CR63","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1099\/ijs.0.02653-0","volume":"54","author":"PA Lawson","year":"2004","unstructured":"Lawson, P. A. et al. Anaerotruncus colihominis gen. nov., sp. nov., from human faeces. Int. J. Syst. Evol. Microbiol. 54, 413\u2013417 (2004).","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"33469_CR64","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.tibtech.2015.06.011","volume":"33","author":"N-R Shin","year":"2015","unstructured":"Shin, N.-R., Whon, T. W. & Bae, J.-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33, 496\u2013503 (2015).","journal-title":"Trends Biotechnol."},{"key":"33469_CR65","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1007\/DCR.0b013e3181f1e620","volume":"53","author":"F Rowan","year":"2010","unstructured":"Rowan, F. et al. Desulfovibrio bacterial species are increased in ulcerative colitis. Dis. Colon Rectum 53, 1530\u20131536 (2010).","journal-title":"Dis. Colon Rectum"},{"key":"33469_CR66","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1128\/JCM.41.6.2752-2754.2003","volume":"41","author":"EJC Goldstein","year":"2003","unstructured":"Goldstein, E. J. C., Citron, D. M., Peraino, V. A. & Cross, S. A. Desulfovibrio desulfuricans Bacteremia and Review of Human Desulfovibrio Infections. J. Clin. Microbiol. 41, 2752\u20132754 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"33469_CR67","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1128\/jcm.30.7.1882-1884.1992","volume":"30","author":"EJ Baron","year":"1992","unstructured":"Baron, E. J. et al. Bilophila wadsworthia isolates from clinical specimens. J. Clin. Microbiol. 30, 1882\u20131884 (1992).","journal-title":"J. Clin. Microbiol."},{"key":"33469_CR68","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1006\/anae.1996.0015","volume":"2","author":"CL Willis","year":"1996","unstructured":"Willis, C. L., Cummings, J. H., Neale, G. & Gibson, G. R. In VitroEffects of Mucin Fermentation on the Growth of Human Colonic Sulphate-Reducing Bacteria: ECOLOGY. Anaerobe 2, 117\u2013122 (1996).","journal-title":"Anaerobe"},{"key":"33469_CR69","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/ismej.2014.3","volume":"8","author":"MG Rooks","year":"2014","unstructured":"Rooks, M. G. et al. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission. ISME J. 8, 1403\u20131417 (2014).","journal-title":"ISME J."},{"key":"33469_CR70","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3181\/0810-RM-301","volume":"234","author":"AM Stringer","year":"2009","unstructured":"Stringer, A. M. et al. Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis. Exp. Biol. Med. 234, 430\u2013441 (2009).","journal-title":"Exp. Biol. Med."},{"key":"33469_CR71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.chom.2017.11.006","volume":"23","author":"CC Gillis","year":"2018","unstructured":"Gillis, C. C. et al. Dysbiosis-Associated Change in Host Metabolism Generates Lactate to Support Salmonella Growth. Cell Host Microbe 23, 54\u201364.e6 (2018).","journal-title":"Cell Host Microbe"},{"key":"33469_CR72","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1016\/j.ces.2010.05.014","volume":"65","author":"OO Oyekola","year":"2010","unstructured":"Oyekola, O. O., van Hille, R. P. & Harrison, S. T. L. Kinetic analysis of biological sulphate reduction using lactate as carbon source and electron donor: Effect of sulphate concentration. Chem. Eng. Sci. 65, 4771\u20134781 (2010).","journal-title":"Chem. Eng. Sci."},{"key":"33469_CR73","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jim.2015.02.005","volume":"421","author":"RP Oliveira","year":"2015","unstructured":"Oliveira, R. P., Santiago, A. F., Ficker, S. M., Gomes-Santos, A. C. & Faria, A. M. C. Antigen administration by continuous feeding enhances oral tolerance and leads to long-lasting effects. J. Immunol. Methods 421, 36\u201343 (2015).","journal-title":"J. Immunol. Methods"},{"key":"33469_CR74","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.1128\/AEM.00934-13","volume":"79","author":"NA Bokulich","year":"2013","unstructured":"Bokulich, N. A. & Mills, D. A. Facility-Specific \u2018House\u2019 Microbiome Drives Microbial Landscapes of Artisan Cheesemaking Plants. Appl. Environ. Microbiol. 79, 5214\u20135223 (2013).","journal-title":"Appl. Environ. Microbiol."},{"issue":"5","key":"33469_CR75","doi-asserted-by":"publisher","first-page":"e36357","DOI":"10.1371\/journal.pone.0036357","volume":"7","author":"Nicholas A. Bokulich","year":"2012","unstructured":"Bokulich, N. A., Joseph, C. M. L., Allen, G., Benson, A. K. & Mills, D. A. Next-Generation Sequencing Reveals Significant Bacterial Diversity of Botrytized Wine. PLoS ONE 7, (2012).","journal-title":"PLoS ONE"},{"key":"33469_CR76","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.mimet.2014.08.018","volume":"107","author":"VS Pylro","year":"2014","unstructured":"Pylro, V. S. et al. Data analysis for 16S microbial profiling from different benchtop sequencing platforms. J. Microbiol. Methods 107, 30\u201337 (2014).","journal-title":"J. Microbiol. Methods"},{"key":"33469_CR77","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","volume":"26","author":"RC Edgar","year":"2010","unstructured":"Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460\u20132461 (2010).","journal-title":"Bioinformatics"},{"key":"33469_CR78","doi-asserted-by":"publisher","first-page":"e2584","DOI":"10.7717\/peerj.2584","volume":"4","author":"T Rognes","year":"2016","unstructured":"Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mah\u00e9, F. VSEARCH: a versatile open source tool for metagenomics. PeerJ 4, e2584 (2016).","journal-title":"PeerJ"},{"key":"33469_CR79","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ DeSantis","year":"2006","unstructured":"DeSantis, T. Z. et al. Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB. Appl. Environ. Microbiol. 72, 5069\u20135072 (2006).","journal-title":"Appl. Environ. Microbiol."},{"key":"33469_CR80","unstructured":"Chao, A. et al. Rarefaction and Extrapolation with Hill Numbers: A Framework for Sampling and Estimation in Species Diversity Studies. (2013)."},{"key":"33469_CR81","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/2041-210X.12613","volume":"7","author":"TC Hsieh","year":"2016","unstructured":"Hsieh, T. C. & Ma, K. H. Chao Anne & McInerny Greg. iNEXT: an R package for rarefaction and extrapolation of species diversity (Hill numbers). Methods Ecol. Evol. 7, 1451\u20131456 (2016).","journal-title":"Methods Ecol. Evol."},{"key":"33469_CR82","doi-asserted-by":"publisher","first-page":"606","DOI":"10.2307\/1940409","volume":"66","author":"M Zimmerman Gregory","year":"1985","unstructured":"Zimmerman Gregory, M., Harold, G. & Mielke Paul W. Use of an Improved Statistical Method for Group Comparisons to Study Effects of Prairie Fire. Ecology 66, 606\u2013611 (1985).","journal-title":"Ecology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33469-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33469-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:51:21Z","timestamp":1720659081000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33469-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33469"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33469-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]},"assertion":[{"value":"22 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15072"}}